Extravascular coagulation and fibrin deposition in acute lung injury
- PMID: 7804805
Extravascular coagulation and fibrin deposition in acute lung injury
Abstract
Extravascular fibrin deposition is characteristic of the acute inflammatory response and is, for example, prominent in the alveolar compartment of patients with the adult respiratory distress syndrome. Fibrin deposition in the injured lung is regulated by a balance of locally expressed pathways of coagulation and fibrin clearance, called fibrinolysis. These pathways comprise part of the interactive network of responses that influence local inflammatory cell traffic, microvascular permeability, and repair mechanisms. In this sense, fibrin turnover in the lung extends beyond traditional hemostasis and may influence the acute inflammatory response and resolution. Within the injured alveolar compartment, fibrin deposition is initiated by increased activity of the extrinsic coagulation pathway-tissue factor associated with factor VII. Activation of the contact and intrinsic coagulation pathways also occurs. Local fibrinolysis is generally impaired, which may potentiate extravascular fibrin deposition. Fibrin turnover in the adult mammalian lung is similarly disrupted in several forms of injury but differs from the injury that occurs in the lungs of premature infants with respiratory distress.
Similar articles
-
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB. Crit Care Med. 2003. PMID: 12682443 Review.
-
The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.Semin Thromb Hemost. 2008 Jul;34(5):475-84. doi: 10.1055/s-0028-1092878. Epub 2008 Oct 27. Semin Thromb Hemost. 2008. PMID: 18956288 Review.
-
Coagulation and inflammation in acute lung injury.Thromb Haemost. 2002 Jul;88(1):17-25. Thromb Haemost. 2002. PMID: 12152667 Review.
-
Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia.Crit Care Med. 2003 Apr;31(4 Suppl):S238-42. doi: 10.1097/01.CCM.0000057849.53689.65. Crit Care Med. 2003. PMID: 12682446 Review.
-
Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.Thromb Haemost. 2008 Mar;99(3):494-501. doi: 10.1160/TH07-11-0666. Thromb Haemost. 2008. PMID: 18327397 Review.
Cited by
-
Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.Am J Respir Crit Care Med. 2010 Jun 15;181(12):1355-66. doi: 10.1164/rccm.200901-0015OC. Epub 2010 Mar 1. Am J Respir Crit Care Med. 2010. PMID: 20194819 Free PMC article.
-
Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice.Am J Respir Cell Mol Biol. 2011 Nov;45(5):1015-21. doi: 10.1165/rcmb.2010-0302OC. Epub 2011 May 26. Am J Respir Cell Mol Biol. 2011. PMID: 21617202 Free PMC article.
-
RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?Clin Transl Immunology. 2021 Mar 18;10(3):e1240. doi: 10.1002/cti2.1240. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33747508 Free PMC article. Review.
-
Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.J Biol Chem. 2011 Jul 1;286(26):23044-53. doi: 10.1074/jbc.M110.210195. Epub 2011 May 3. J Biol Chem. 2011. PMID: 21540184 Free PMC article.
-
Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.J Thromb Haemost. 2016 Dec;14(12):2471-2477. doi: 10.1111/jth.13504. Epub 2016 Oct 24. J Thromb Haemost. 2016. PMID: 27622544 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources